HUTCHMED (China) Stock Forecast
NASDAQ: HCMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 13.68 +0.07%
HCM analyst consensus
Consensus (13 analysts)
strong_buy
Avg. price target
$22.01+61.01%
- Strong buy 2
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 13 Wall Street analysts covering HUTCHMED (China) (2026-10-07), 11 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $22.01, with a high estimate of $40.40 and a low estimate of $13.60. The average target implies upside of 61.0% from the current price of $13.67.
The spread between the highest and lowest targets is 197.1%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HCM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 15% |
| Buy | 9 | 69% |
| Hold | 2 | 15% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $13.60 | -0.51% |
| Average target | $22.01 | +61.01% |
| High target | $40.40 | +195.54% |